… biomarkers have been identified. Furthermore, recent advances in genomic studies of bladder
cancer … identified biomarkers and genomic landscape of bladder cancer will be reviewed. …

… genomic and genetic biomarkers, self-reported race, and AIMs are associated with kidney,
prostate, and bladder cancer … genomic trials for kidney, prostate, and bladder cancers. As …

… biomarkers of bladder cancer have been identified. Two separate approaches to biomarker
… expression of genes (so-called ‘genomics’) looking for characteristic signatures associated …

… on molecular biomarkers and evaluate their potential role as new molecules for bladder
cancer … are described in the literature aiming to detect genomic, transcriptomic, epigenetic or …

… reported in bladder cancer for over 2 decades, the recent in-depth genomic analyses have
extended our knowledge of the role of cell-cycle gene events in bladder cancer, including …

… To better define the prevalence and co-occurrence patterns of potentially actionable genomic
alterations in NMIBC, we analyzed known cancer-associated genes within the context of …

… for patients with muscle-invasive bladder cancer (MIBC). It has … was to validate these genomic
biomarkers in pretreatment … In an exploratory analysis, no additional genomic alterations …

… Bladder cancer, like all cancers, has associated genetic driving events that are common in
all patients. For example, genomic alterations, such as somatic mutations in the FGFR3 gene (…

Bladder cancers are a mixture of heterogeneous cell … the biomarkers reported to date have
shown sufficient sensitivity and specificity for detecting the whole spectrum of bladder cancer …

… of the molecular and genomic characteristics of bladder cancer through next-generation …
potential molecular biomarkers for muscle-invasive bladder cancer. These biomarkers can be …